# FDA 483 - Joseph L. Lillo, D.O. - December 09, 2019

Source: https://www.globalkeysolutions.net/records/483/joseph-l-lillo-do/3cb3f785-3fa7-4e4d-b237-62fcd109b8b1

> FDA 483 for Joseph L. Lillo, D.O. on December 09, 2019. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Joseph L. Lillo, D.O.
- Inspection Date: 2019-12-09
- Product Type: drugs
- Office Name: Denver District Office
- Summary: An FDA inspection of Joseph L. Lillo, D.O. in Phoenix, AZ, a clinical investigator, revealed a significant issue regarding the maintenance of accurate case histories and informed consent. Specifically, an informed consent form was not properly signed by the Clinical Investigator, and eDiary symptom documentation for a subject was inconsistent. These findings indicate deficiencies in record-keeping and adherence to study protocols.

## Related Documents

- [483 - 2021-03-22](https://www.globalkeysolutions.net/records/483/joseph-l-lillo-do/d65fcd27-e80d-49f3-a8d7-c82d6fa4141f)

## Related Officers

- [issuing_officer](https://www.globalkeysolutions.net/people/michelle-j-hines/c8087e41-6b8a-4b9a-92ad-bba500ce6fee)

Company: https://www.globalkeysolutions.net/companies/joseph-l-lillo-do/1ea0d267-f3a4-4b8f-9611-61ba95abc6b1

Office: https://www.globalkeysolutions.net/offices/denver-district-office/93b79063-390c-4759-af6c-5da7e388face